Steinert Disease: Clinical Trials

7 trials for Steinert Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 1 enrolling by invitation, 1 unknown. 3 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Enrolling by invitation 1, Recruiting 1
Not applicable1Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Steinert Disease: new trials by email Literature Review of Steinert Disease trials Research Report on Steinert Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
zeleciment basivarsen (DYNE-101), Placebo - Myotonic Dystrophy Type 1 (DM1), DM1
Phase 3RecruitingDyne Therapeutics1502026-05-142026-10-13
Global Open-Label Extension Study of Del-desiran for the Treatment of DM1
Del-desiran (AOC 1001) - Myotonic Dystrophy Type 1, DM1
Phase 3Enrolling by invitationAvidity Biosciences, Inc.1992025-06-262026-08-19
The Spanish National Registry for Myotonic Dystrophy Type 1
Patient Registry - Myotonic Dystrophy 1, DM1
RecruitingFundació Institut Germans Trias i Pujol30002025-06-022026-02-04
Global Study of Del-desiran for the Treatment of DM1
AOC 1001 (del-desiran), Placebo - DM1, Myotonic Dystrophy
Phase 3CompletedAvidity Biosciences, Inc.1592024-05-302026-09-01
Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients
AOC 1001, Placebo - DM1, Myotonic Dystrophy 1
Phase 1 / Phase 2CompletedAvidity Biosciences, Inc.392021-10-282026-09-28
Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy
Non Invasive Ventilation. - Myotonic Dystrophy 1, Steinert Disease
Not applicableUnknownNational Institute of Respiratory Diseases, Mexico272016-09-012018-07-11
Myotonic Dystrophy Family Registry
Patient-entered data - Myotonic Dystrophy, Congenital Myotonic Dystrophy
RecruitingMyotonic Dystrophy Foundation35002013-02-012024-11-21

Narrower conditions

Myotonic Dystrophy (7)  ·  Myotonic Disorders (4)  ·  Myotonia (3)  ·  Respiratory Insufficiency (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7)  ·  Genetic Diseases, Inborn (7)  ·  Heredodegenerative Disorders, Nervous System (7)  ·  Muscular Diseases (7)  ·  Muscular Disorders, Atrophic (7)  ·  Muscular Dystrophies (7)  ·  Musculoskeletal Diseases (7)  ·  Nervous System Diseases (7)  ·  Neurodegenerative Diseases (7)  ·  Neuromuscular Diseases (7)  ·  Myotonic Disorders (3)  ·  Neurologic Manifestations (3)  ·  Neuromuscular Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)

Interventions

Noninvasive Ventilation (1)

Sponsors

Avidity Biosciences, Inc. (3)  ·  Dyne Therapeutics (1)  ·  Fundació Institut Germans Trias i Pujol (1)  ·  Myotonic Dystrophy Foundation (1)  ·  National Institute of Respiratory Diseases, Mexico (1)

Countries

United States (5)  ·  Spain (4)  ·  Denmark (3)  ·  France (3)  ·  Germany (3)  ·  Italy (3)  ·  Japan (3)  ·  Netherlands (3)  ·  United Kingdom (3)  ·  Canada (2)  ·  Australia (1)  ·  Belgium (1)  ·  Mexico (1)

Top investigators

Arturo Lopez Castel, Ph.D. (1)  ·  Gisela Nogales Gadea, Ph.D. (1)  ·  Li Tai, MD (1)  ·  Martha G Torres Fraga, MD (1)  ·  Rogelio Perez Padilla, MD (1)  ·  Tanya Stevenson, EdD, MPH (1)  ·  Virginia Arechavala-Gomeza, Ph.D. (1)

Results publications

PMID 10836341, PMID 11972163, PMID 12351998, PMID 24803843, PMID 25753091, PMID 4047090, PMID 41707138, PMID 563010

NIH funding

2025 (1)